Drug Type Small molecule drug |
Synonyms CAL 005, CAL005 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Preclinical | Taiwan Province | 01 Nov 2025 | |
| Inflammatory Bowel Diseases | Preclinical | Taiwan Province | 01 Nov 2025 | |
| Bile Duct Neoplasms | Preclinical | Taiwan Province | 01 Aug 2023 | |
| Breast Cancer | Preclinical | Taiwan Province | 01 Aug 2023 | |
| Colonic Cancer | Preclinical | Taiwan Province | 01 Aug 2023 | |
| Leukemia | Preclinical | Taiwan Province | 01 Aug 2023 | |
| Prostatic Cancer | Preclinical | Taiwan Province | 01 Aug 2023 | |
| Virus Diseases | Preclinical | Taiwan Province | - |





